SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-18-007491
Filing Date
2018-04-23
Accepted
2018-04-23 17:09:31
Documents
5
Effectiveness Date
2018-04-23

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A acrx20180421_defa14a.htm DEFA14A 18942
2 notice4.jpg GRAPHIC 67306
3 notice3.jpg GRAPHIC 67412
4 notice2.jpg GRAPHIC 203801
5 notice1.jpg GRAPHIC 156903
  Complete submission text file 0001437749-18-007491.txt   701445
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35068 | Film No.: 18769489
SIC: 2834 Pharmaceutical Preparations